Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2024 | Orange Dental | $130.0M Series B | Oceanpine Capital, OrbiMed | Adjuvant Capital, AIHC Capital, Eight Roads Ventures, F-Prime Capital, Haitong International, Hillhouse Capital Group, MSA Capital, Superstring Capital |
| Aug 23, 2021 | OPay | $400.0M Series C | Kentaro Matsui | DragonBall Capital, Hongshan Capital Group (Sequoia Capital China), Redpoint China, SoftBank Ventures Asia, Source Code Capital |
| Feb 1, 2021 | LakeShore Biopharma | $130.0M Series B | OrbiMed, Dave Chenn | Adjuvant Capital, AIHC Capital, Eight Roads Ventures, Epiphron Capital, F-Prime Capital, Haitong International, Hillhouse Capital, MSA Capital, Superstring Capital |